These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9826539

  • 1. Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.
    Delgado MD, Gutiérrez P, Richard C, Cuadrado MA, Moreau-Gachelin F, León J.
    Biochem Biophys Res Commun; 1998 Nov 18; 252(2):383-91. PubMed ID: 9826539
    [Abstract] [Full Text] [Related]

  • 2. Interferon induces up-regulation of Spi-1/PU.1 in human leukemia K562 cells.
    Gutiérrez P, Delgado MD, Richard C, Moreau-Gachelin F, León J.
    Biochem Biophys Res Commun; 1997 Nov 26; 240(3):862-8. PubMed ID: 9398659
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R, Théoleyre O, Douablin A, Baklouti F.
    Cell Res; 2008 Aug 26; 18(8):834-45. PubMed ID: 18560381
    [Abstract] [Full Text] [Related]

  • 4. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T, Yamada T, Kihara-Negishi F, Yamamoto H, Kondoh N, Hitomi Y, Hashimoto Y.
    Cell Death Differ; 1999 Jul 26; 6(7):599-608. PubMed ID: 10453070
    [Abstract] [Full Text] [Related]

  • 5. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
    Breig O, Théoleyre O, Douablin A, Baklouti F.
    Oncogene; 2010 May 13; 29(19):2807-16. PubMed ID: 20190819
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
    Delgado MD, Hallier M, Meneceur P, Tavitian A, Moreau-Gachelin F.
    Oncogene; 1994 Jun 13; 9(6):1723-7. PubMed ID: 8183568
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
    Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, Ghysdael J.
    Oncogene; 1999 Feb 25; 18(8):1597-608. PubMed ID: 10102630
    [Abstract] [Full Text] [Related]

  • 10. ERF, an ETS-related transcriptional repressor, can induce erythroid differentiation.
    Athanasiou M, Blair DG, Mavrothalassitis G.
    Anticancer Res; 2003 Feb 25; 23(3A):2143-53. PubMed ID: 12894589
    [Abstract] [Full Text] [Related]

  • 11. Prevention of PU.1-induced growth inhibition and apoptosis but not differentiation block in murine erythroleukemia cells by overexpression of CBP.
    Manabe N, Yamamoto H, Yamada T, Kihara-Negishi F, Hashimoto Y, Mochizuki M, Oikawa T.
    Int J Oncol; 2003 Jun 25; 22(6):1345-50. PubMed ID: 12739003
    [Abstract] [Full Text] [Related]

  • 12. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H, Potter M, Ellis J, Grosveld GC.
    Cancer Res; 2004 Sep 01; 64(17):6091-100. PubMed ID: 15342392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells.
    Delva L, Gallais I, Guillouf C, Denis N, Orvain C, Moreau-Gachelin F.
    Oncogene; 2004 May 27; 23(25):4389-99. PubMed ID: 15064749
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
    Dekoninck A, Calomme C, Nizet S, de Launoit Y, Burny A, Ghysdael J, Van Lint C.
    Oncogene; 2003 May 15; 22(19):2882-96. PubMed ID: 12771939
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the promoter region of the human PARG gene and its response to PU.1 during differentiation of HL-60 cells.
    Uchiumi F, Sakakibara G, Sato J, Tanuma S.
    Genes Cells; 2008 Dec 15; 13(12):1229-47. PubMed ID: 19076642
    [Abstract] [Full Text] [Related]

  • 17. Inducible expression of the megakaryocyte-specific gene glycoprotein IX is mediated through an Ets binding site and involves upstream activation of extracellular signal-regulated kinase.
    Eisbacher M, Khachigian LM, Khin TH, Holmes ML, Chong BH.
    Cell Growth Differ; 2001 Aug 15; 12(8):435-45. PubMed ID: 11504709
    [Abstract] [Full Text] [Related]

  • 18. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C.
    DeKoter RP, Geadah M, Khoosal S, Xu LS, Thillainadesan G, Torchia J, Chin SS, Garrett-Sinha LA.
    J Immunol; 2010 Dec 15; 185(12):7374-84. PubMed ID: 21057087
    [Abstract] [Full Text] [Related]

  • 19. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA, Kittrell FS, Medina D, Butel JS.
    Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642
    [Abstract] [Full Text] [Related]

  • 20. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
    Yamada T, Shimizu T, Suzuki M, Kihara-Negishi F, Nanashima N, Sakurai T, Fan Y, Akita M, Oikawa T, Tsuchida S.
    Exp Cell Res; 2008 Feb 15; 314(4):847-58. PubMed ID: 18076876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.